|
1
|
Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
|
Biochem J
|
2003
|
10.77
|
|
2
|
Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
|
J Immunol
|
2003
|
1.92
|
|
3
|
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
|
Gastroenterology
|
2006
|
1.68
|
|
4
|
Nucleocytoplasmic shuttling of persistently activated STAT3.
|
J Cell Sci
|
2007
|
1.31
|
|
5
|
Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction.
|
J Immunol
|
2002
|
1.29
|
|
6
|
Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase.
|
J Biol Chem
|
2004
|
1.22
|
|
7
|
Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases.
|
J Cell Mol Med
|
2010
|
1.19
|
|
8
|
A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.
|
Eur J Biochem
|
2002
|
1.12
|
|
9
|
The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression.
|
J Biol Chem
|
2005
|
1.10
|
|
10
|
Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes.
|
Hepatology
|
2009
|
1.07
|
|
11
|
Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
|
Mol Cancer Res
|
2007
|
1.02
|
|
12
|
STAT3 is enriched in nuclear bodies.
|
J Cell Sci
|
2003
|
1.00
|
|
13
|
The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
|
Biochem J
|
2004
|
0.98
|
|
14
|
Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.
|
J Biol Chem
|
2005
|
0.98
|
|
15
|
Are STATS arginine-methylated?
|
J Biol Chem
|
2005
|
0.95
|
|
16
|
Development of an IL-6 inhibitor based on the functional analysis of murine IL-6Ralpha(1).
|
Chem Biol
|
2009
|
0.87
|
|
17
|
A fusion protein of the gp130 and interleukin-6Ralpha ligand-binding domains acts as a potent interleukin-6 inhibitor.
|
J Biol Chem
|
2003
|
0.86
|
|
18
|
An unusual insertion in Jak2 is crucial for kinase activity and differentially affects cytokine responses.
|
J Immunol
|
2009
|
0.85
|
|
19
|
The chemoattractants, IL-8 and formyl-methionyl-leucyl-phenylalanine, regulate granulocyte colony-stimulating factor signaling by inducing suppressor of cytokine signaling-1 expression.
|
J Immunol
|
2004
|
0.85
|
|
20
|
Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses.
|
Cell Commun Signal
|
2010
|
0.83
|
|
21
|
Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130.
|
Cell Signal
|
2005
|
0.79
|
|
22
|
Bow to your partner for signaling.
|
Nat Struct Mol Biol
|
2005
|
0.77
|
|
23
|
Co-immunoprecipitation protocol to investigate cytokine receptor-associated proteins, e.g., Janus kinases or other associated signaling proteins.
|
Methods Mol Biol
|
2013
|
0.77
|
|
24
|
JAK2-V617F-induced MAPK activity is regulated by PI3K and acts synergistically with PI3K on the proliferation of JAK2-V617F-positive cells.
|
JAKSTAT
|
2013
|
0.76
|
|
25
|
Software tools of the Computis European project to process mass spectrometry images.
|
Eur J Mass Spectrom (Chichester, Eng)
|
2014
|
0.75
|